Pfizer Inc. (PFE)Healthcare | Drug Manufacturers - General | New York, United States | NYSE
27.96 USD
-0.06
(-0.214%) ⇩
(Aug. 28, 2026, 4:01 p.m.
EDT)
After hours: 27.95 -0.01 (-0.010%) ⇩ (Aug. 28, 2026, 7:59 p.m. EDT) |
Hot Take ↕ | Aug. 22, 2026, 2:59 a.m. EDT
The immediate outlook is mixed but leans cautiously bearish due to a severe disconnect between the company's recent performance and its valuation. Fundamentally, the business is in a structural decline, having lost nearly 22% of its value over the last nine years with four consecutive years of negative annual returns. This persistent deterioration suggests the market views the current price as unjustified despite the low forward P/E. However, the stock is currently trading at a premium to its historical range, which may limit further downside in the very short term. The options market confirms this tension: traders are buying protection at the $27 level while speculating on a bounce to $30, but the heavy put open interest acts as a ceiling. The high dividend yield is a compensation for the lack of capital appreciation and the risk of payout cuts given the weak free cash flow relative to debt obligations. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 0.028017 |
| MSTL | 0.028571 |
| AutoARIMA | 0.028582 |
| AutoETS | 0.028744 |
Forecast horizon: 45 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 55% |
| H-stat | 0.61 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.487 |
| Excess Kurtosis | -0.81 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Ex Dividend Date | 2026-07-23 |
| Last Dividend Date | 2026-07-23 |
| Debt to Equity Ratio | 74.253 |
| Revenue per Share | 11.193 |
| Market Cap | 159,362,875,392 |
| Trailing P/E | 36.79 |
| Forward P/E | 9.66 |
| Beta | 0.28 |
| Profit Margins | 6.80% |
| Website | https://www.pfizer.com |
As of Aug. 22, 2026, 2:59 a.m. EDT: Speculators are positioning defensively with heavy put volume concentrated at the $27 strike, creating a significant wall of resistance. While there is notable call volume at the $30 level suggesting a speculative bid for a rebound, the overwhelming open interest in out-of-the-money puts indicates a fear of further downside or a 'cap' at current levels rather than a breakout scenario.
| Last Yield | 1yr Yield | 3yr Avg | 5yr Avg |
|---|---|---|---|
| 1.75% | 6.86% | 6.50% | 5.35% |
| Date | Dividend | Yield % |
|---|---|---|
| 2026-07-24 | 0.430000 | 1.752241 |
| 2026-05-08 | 0.430000 | 1.674455 |
| 2026-01-23 | 0.430000 | 1.676413 |
| 2025-11-07 | 0.430000 | 1.760131 |
| 2025-07-25 | 0.430000 | 1.734570 |
| 2025-05-09 | 0.430000 | 1.929982 |
| 2025-01-24 | 0.430000 | 1.648141 |
| 2024-11-08 | 0.420000 | 1.571856 |
| 2024-07-26 | 0.420000 | 1.364966 |
| 2024-05-09 | 0.420000 | 1.490419 |
| 2024-01-25 | 0.420000 | 1.528941 |
| 2023-11-09 | 0.410000 | 1.381402 |
| 2023-07-27 | 0.410000 | 1.132597 |
| 2023-05-11 | 0.410000 | 1.091006 |
| 2023-01-26 | 0.410000 | 0.926554 |
| 2022-11-03 | 0.400000 | 0.858922 |
| 2022-07-28 | 0.400000 | 0.788644 |
| 2022-05-12 | 0.400000 | 0.793808 |
| 2022-01-27 | 0.400000 | 0.749485 |
| 2021-11-04 | 0.390000 | 0.889396 |
| 2021-07-29 | 0.390000 | 0.911428 |
| 2021-05-06 | 0.390000 | 0.995152 |
| 2021-01-28 | 0.390000 | 1.087563 |
| 2020-11-05 | 0.360531 | 1.044242 |
| 2020-07-30 | 0.360531 | 0.980897 |
| 2020-05-07 | 0.360531 | 1.028138 |
| 2020-01-30 | 0.360531 | 1.025087 |
| 2019-11-07 | 0.341556 | 0.975346 |
| 2019-08-01 | 0.341556 | 0.941177 |
| 2019-05-09 | 0.341556 | 0.885827 |
| 2019-01-31 | 0.341556 | 0.848057 |
| 2018-11-08 | 0.322581 | 0.775371 |
| 2018-08-02 | 0.322581 | 0.857504 |
| 2018-05-10 | 0.322581 | 0.970321 |
| 2018-02-01 | 0.322581 | 0.923162 |
| 2017-11-09 | 0.303605 | 0.909090 |
| 2017-08-02 | 0.303605 | 0.972052 |
| 2017-05-10 | 0.303605 | 0.968815 |
| 2017-02-01 | 0.303605 | 1.010419 |
| 2016-11-08 | 0.284630 | 1.000000 |
| 2016-08-03 | 0.284630 | 0.850099 |
| 2016-05-11 | 0.284630 | 0.904704 |
| 2016-02-03 | 0.284630 | 1.011122 |
| 2015-11-04 | 0.265655 | 0.820153 |
| 2015-08-05 | 0.265655 | 0.781687 |
| 2015-05-06 | 0.265655 | 0.836821 |
| 2015-02-04 | 0.265655 | 0.873091 |
| 2014-11-05 | 0.246679 | 0.865512 |
| 2014-07-30 | 0.246679 | 0.888584 |
| 2014-05-07 | 0.246679 | 0.895933 |
| 2014-02-05 | 0.246679 | 0.848286 |
| 2013-11-06 | 0.227704 | 0.774944 |
| 2013-07-31 | 0.227704 | 0.821074 |
| 2013-05-08 | 0.227704 | 0.835364 |
| 2013-01-30 | 0.227704 | 0.872410 |
| 2012-11-07 | 0.208729 | 0.910221 |
| 2012-08-01 | 0.208729 | 0.918966 |
| 2012-05-09 | 0.208729 | 0.979957 |
| 2012-02-01 | 0.208729 | 1.032381 |
| 2011-11-08 | 0.189753 | 0.996014 |
| 2011-08-03 | 0.189753 | 1.109260 |
| 2011-05-11 | 0.189753 | 0.970401 |
| 2011-02-02 | 0.189753 | 1.054851 |
| 2010-11-04 | 0.170778 | 1.035673 |
| 2010-08-04 | 0.170778 | 1.094891 |
| 2010-05-05 | 0.170778 | 1.047730 |
| 2010-02-03 | 0.170778 | 0.966703 |
| 2009-11-04 | 0.151803 | 0.945070 |
| 2009-08-05 | 0.151803 | 1.008194 |
| 2009-05-06 | 0.151803 | 1.150254 |
| 2009-02-04 | 0.303605 | 2.196292 |
| 2008-11-05 | 0.303605 | 1.882351 |
| 2008-08-06 | 0.303605 | 1.646936 |
| 2008-05-07 | 0.303605 | 1.606424 |
| 2008-02-06 | 0.303605 | 1.416554 |
| 2007-11-07 | 0.275142 | 1.243566 |
| 2007-08-08 | 0.275142 | 1.178381 |
| 2007-05-09 | 0.275142 | 1.067745 |
| 2007-02-07 | 0.275142 | 1.093513 |
| 2006-11-08 | 0.227704 | 0.901578 |
| 2006-08-09 | 0.227704 | 0.917782 |
| 2006-05-10 | 0.227704 | 0.958466 |
| 2006-02-08 | 0.227704 | 0.910125 |
| 2005-11-08 | 0.180266 | 0.867186 |
| 2005-08-10 | 0.180266 | 0.719971 |
| 2005-05-11 | 0.180266 | 0.687162 |
| 2005-02-09 | 0.180266 | 0.758484 |
| 2004-11-09 | 0.161290 | 0.607359 |
| 2004-08-11 | 0.161290 | 0.535095 |
| 2004-05-12 | 0.161290 | 0.476056 |
| 2004-02-11 | 0.161290 | 0.445609 |
| 2003-11-12 | 0.142315 | 0.462963 |
| 2003-08-13 | 0.142315 | 0.475285 |
| 2003-05-14 | 0.142315 | 0.451671 |
| 2003-01-15 | 0.142315 | 0.492611 |
| 2002-11-13 | 0.123340 | 0.398774 |
| 2002-08-14 | 0.123340 | 0.392750 |
| 2002-05-15 | 0.123340 | 0.356263 |
| 2002-02-13 | 0.123340 | 0.316380 |
| 2001-11-14 | 0.104364 | 0.259556 |
| 2001-08-15 | 0.104364 | 0.266925 |
| 2001-05-16 | 0.104364 | 0.246525 |
| 2001-02-14 | 0.104364 | 0.243362 |
| 2000-11-15 | 0.085389 | 0.208999 |
| 2000-08-16 | 0.085389 | 0.207194 |
| 2000-05-09 | 0.085389 | 0.201681 |
| 2000-02-16 | 0.085389 | 0.266667 |
| 1999-11-09 | 0.075901 | 0.228570 |
| 1999-08-04 | 0.075901 | 0.240149 |
| 1999-05-05 | 0.069576 | 0.185948 |
| 1999-02-10 | 0.069576 | 0.173569 |
| 1998-11-04 | 0.060089 | 0.179247 |
| 1998-08-05 | 0.060089 | 0.179458 |
| 1998-05-06 | 0.060089 | 0.174814 |
| 1998-02-04 | 0.060089 | 0.233489 |
| 1997-11-05 | 0.053763 | 0.230117 |
| 1997-07-30 | 0.053763 | 0.286012 |
| 1997-05-07 | 0.053763 | 0.350513 |
| 1997-02-05 | 0.053763 | 0.383636 |
| 1996-11-06 | 0.047438 | 0.338981 |
| 1996-07-31 | 0.047438 | 0.429335 |
| 1996-05-08 | 0.047438 | 0.458888 |
| 1996-02-07 | 0.047438 | 0.441986 |
| 1995-11-08 | 0.041113 | 0.427981 |
| 1995-08-02 | 0.041113 | 0.514849 |
| 1995-05-08 | 0.041113 | 0.600285 |
| 1995-02-06 | 0.041113 | 0.639997 |
| 1994-11-04 | 0.037160 | 0.644939 |
| 1994-08-01 | 0.037160 | 0.764227 |
| 1994-05-09 | 0.037160 | 0.789915 |
| 1994-02-07 | 0.037160 | 0.762677 |
| 1993-11-05 | 0.033207 | 0.662725 |
| 1993-08-02 | 0.033207 | 0.701465 |
| 1993-05-10 | 0.033207 | 0.615388 |
| 1993-02-08 | 0.033207 | 0.674702 |
| 1992-11-16 | 0.029254 | 0.483666 |
| 1992-08-03 | 0.029254 | 0.466883 |
| 1992-05-11 | 0.029254 | 0.514789 |
| 1992-02-03 | 0.029254 | 0.510351 |
| 1991-11-08 | 0.026091 | 0.477395 |
| 1991-08-01 | 0.026091 | 0.529056 |
| 1991-05-13 | 0.026091 | 0.581496 |
| 1991-02-22 | 0.026091 | 0.648647 |
| 1990-11-09 | 0.023719 | 0.785592 |
| 1990-08-06 | 0.023719 | 0.875906 |
| 1990-05-14 | 0.023719 | 0.991729 |
| 1990-02-05 | 0.023719 | 0.866420 |
| 1989-11-13 | 0.021743 | 0.780157 |
| 1989-07-24 | 0.021743 | 0.934201 |
| 1989-05-15 | 0.021743 | 0.866159 |
| 1989-01-23 | 0.021743 | 0.979975 |
| 1988-11-15 | 0.019766 | 0.911163 |
| 1988-07-25 | 0.019766 | 0.995026 |
| 1988-05-16 | 0.019766 | 0.966185 |
| 1988-02-12 | 0.019766 | 0.954655 |
| 1987-11-16 | 0.017789 | 0.859171 |
| 1987-07-27 | 0.017789 | 0.619608 |
| 1987-05-14 | 0.017789 | 0.672883 |
| 1987-01-26 | 0.017789 | 0.687008 |
| 1986-11-17 | 0.016208 | 0.681909 |
| 1986-07-28 | 0.016208 | 0.620034 |
| 1986-05-14 | 0.016208 | 0.690522 |
| 1986-01-27 | 0.016208 | 0.863153 |
| 1985-11-15 | 0.014627 | 0.745601 |
| 1985-07-26 | 0.014627 | 0.745601 |
| 1985-05-20 | 0.014627 | 0.745601 |
| 1985-01-28 | 0.014627 | 0.933766 |
| 1984-11-13 | 0.013046 | 0.851643 |
| 1984-07-26 | 0.013046 | 1.035330 |
| 1984-05-14 | 0.013046 | 1.003837 |
| 1984-01-26 | 0.013046 | 0.916699 |
| 1983-11-14 | 0.011464 | 0.709464 |
| 1983-07-26 | 0.011464 | 0.692521 |
| 1983-05-13 | 0.011464 | 0.695636 |
| 1983-01-26 | 0.011464 | 0.828552 |
| 1982-11-15 | 0.009092 | 0.649005 |
| 1982-07-27 | 0.009092 | 0.796506 |
| 1982-05-13 | 0.009092 | 0.826935 |
| 1982-01-26 | 0.009092 | 0.865850 |
| 1981-11-13 | 0.007906 | 0.842064 |
| 1981-08-13 | 0.007906 | 0.824701 |
| 1981-05-13 | 0.007906 | 0.771046 |
| 1981-02-11 | 0.007906 | 0.824701 |
| 1980-11-28 | 0.007116 | 0.727298 |
| 1980-09-02 | 0.007116 | 0.862306 |
| 1980-05-29 | 0.007116 | 0.883467 |
| 1980-03-04 | 0.007116 | 1.014120 |
| 1979-11-23 | 0.006523 | 0.827615 |
| 1979-08-28 | 0.006523 | 0.929610 |
| 1979-05-24 | 0.006523 | 1.128244 |
| 1979-03-06 | 0.006523 | 1.043515 |
| 1978-11-22 | 0.005930 | 0.905692 |
| 1978-08-29 | 0.005930 | 0.857173 |
| 1978-05-26 | 0.005930 | 0.933885 |
| 1978-02-28 | 0.005337 | 1.043516 |
| 1977-11-25 | 0.005337 | 0.968645 |
| 1977-09-02 | 0.004744 | 0.893055 |
| 1977-05-31 | 0.004744 | 0.960034 |
| 1977-03-01 | 0.004744 | 0.861018 |
| 1976-11-26 | 0.004349 | 0.818697 |
| 1976-08-31 | 0.004349 | 0.775418 |
| 1976-06-01 | 0.004151 | 0.767151 |
| 1976-03-02 | 0.004151 | 0.767151 |
| 1975-11-28 | 0.004744 | 0.861018 |
| 1975-09-02 | 0.003756 | 0.734391 |
| 1975-05-27 | 0.003756 | 0.550793 |
| 1975-03-04 | 0.003756 | 0.527843 |
| 1974-11-25 | 0.004744 | 0.780515 |
| 1974-08-27 | 0.003756 | 0.760095 |
| 1974-05-29 | 0.003756 | 0.550793 |
| 1974-03-05 | 0.003360 | 0.426305 |
| 1973-11-27 | 0.004349 | 0.498640 |
| 1973-08-28 | 0.003163 | 0.354621 |
| 1973-05-30 | 0.003163 | 0.378752 |
| 1973-02-28 | 0.003163 | 0.377634 |
| 1972-11-28 | 0.004151 | 0.484167 |
| 1972-08-29 | 0.003163 | 0.368928 |
| Attribute | Value |
|---|---|
| 52 Week Change | 0.11929548 |
| Address1 | 66 Hudson Boulevard East |
| All Time High | 61.71 |
| All Time Low | 0.427439 |
| Ask | 27.97 |
| Ask Size | 19,700 |
| Audit Risk | 7 |
| Average Analyst Rating | 2.5 - Buy |
| Average Daily Volume10 Day | 33,931,360 |
| Average Daily Volume3 Month | 42,052,501 |
| Average Volume | 42,052,501 |
| Average Volume10Days | 33,931,360 |
| Beta | 0.28 |
| Bid | 27.89 |
| Bid Size | 3,800 |
| Board Risk | 7 |
| Book Value | 14.948 |
| City | New York |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Compensation Risk | 9 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 27.96 |
| Current Ratio | 1.267 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,786,665,600 |
| Day High | 28.02 |
| Day Low | 27.77 |
| Debt To Equity | 74.253 |
| Display Name | Pfizer |
| Dividend Date | 1,788,220,800 |
| Dividend Rate | 1.72 |
| Dividend Yield | 6.14 |
| Earnings Call Timestamp End | 1,785,852,000 |
| Earnings Call Timestamp Start | 1,785,852,000 |
| Earnings Timestamp | 1,785,846,600 |
| Earnings Timestamp End | 1,793,709,000 |
| Earnings Timestamp Start | 1,793,709,000 |
| Ebitda | 25,383,000,064 |
| Ebitda Margins | 0.3985 |
| Enterprise To Ebitda | 8.33 |
| Enterprise To Revenue | 3.32 |
| Enterprise Value | 211,440,877,568 |
| Eps Current Year | 2.97515 |
| Eps Forward | 2.8954 |
| Eps Trailing Twelve Months | 0.76 |
| Esg Populated | 0 |
| Ex Dividend Date | 1,784,851,200 |
| Exchange | NYQ |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 25.5706 |
| Fifty Day Average Change | 2.3893986 |
| Fifty Day Average Change Percent | 0.09344319 |
| Fifty Two Week Change Percent | 11.929548 |
| Fifty Two Week High | 28.75 |
| Fifty Two Week High Change | -0.7900009 |
| Fifty Two Week High Change Percent | -0.027478293 |
| Fifty Two Week Low | 23.58 |
| Fifty Two Week Low Change | 4.379999 |
| Fifty Two Week Low Change Percent | 0.1857506 |
| Fifty Two Week Range | 23.58 - 28.75 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 76,253,400,000 |
| Five Year Avg Dividend Yield | 5.16 |
| Float Shares | 5,692,207,017 |
| Forward Eps | 2.8954 |
| Forward P E | 9.656696 |
| Free Cashflow | 12,485,624,832 |
| Full Exchange Name | NYSE |
| Full Time Employees | 75,000 |
| Fullday Change | -0.0600014 |
| Fullday Change Percent | -0.214138 |
| Fullday Price | 27.95 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,785,542,400 |
| Gross Margins | 0.74716 |
| Gross Profits | 47,590,998,016 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.00101 |
| Held Percent Institutions | 0.69151 |
| Implied Shares Outstanding | 5,699,673,589 |
| Industry | Drug Manufacturers - General |
| Industry Disp | Drug Manufacturers - General |
| Industry Key | drug-manufacturers-general |
| Ir Website | http://www.pfizer.com/investors/ |
| Is Earnings Date Estimate | 0 |
| Language | en-US |
| Last Dividend Date | 1,784,851,200 |
| Last Dividend Value | 0.43 |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,605,571,200 |
| Last Split Factor | 1,054:1000 |
| Long Business Summary | Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and Paxlovid for the treatment of COVID-19. It also provides inflammation and immunology products, such as Xeljanz, Enbrel, Cibinqo, Litfulo, Eucrisa, and Velsipity; rare disease products for therapeutic areas comprising amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel family, Genotropin, BeneFIX, Xyntha, Somavert, Ngenla, and Hympavzi brands; and anti-infective and immunoglobulin medicines under the Zavicefta, Octagam, and Panzyga brands. In addition, the company offers oncology products comprising ADCs, small molecules, bispecific, and other immunotherapies for the treatment of cancers, including breast cancer, genitourinary cancer, and hematologic malignancies, as well as melanoma, gastrointestinal, gynecological, and lung cancer under the Ibrance, Xtandi, Padcev, Adcetris, Inlyta, Lorbrena, Bosulif, Tukysa, Braftovi, Mektovi, Orgovyx, Elrexfio, Tivdak, and Talzenna brands. Further, it provides biosimilars under the Inflectra brand; oncology biosimilars comprising Retacrit, Ruxience, Zirabev, Trazimera and Nivestym, and other biosimilars; and sterile injectables, such as Sulperazon, Atgam, Fragmin, Solu Medrol, Solu Cortef, and Bicillin. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE, as well as a strategic collaboration with Boltz, PBC to develop and deploy biomolecular AI foundation models. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York. |
| Long Name | Pfizer Inc. |
| Market | us_market |
| Market Cap | 159,362,875,392 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_162270 |
| Most Recent Quarter | 1,782,604,800 |
| Net Income To Common | 4,338,999,808 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 159,704,853,963 |
| Number Of Analyst Opinions | 26 |
| Open | 28.0 |
| Operating Cashflow | 13,400,999,936 |
| Operating Margins | 0.27877 |
| Overall Risk | 7 |
| Payout Ratio | 2.2632 |
| Peg Ratio | 2.71 |
| Phone | 212 733 2323 |
| Post Market Change | -0.0099983215 |
| Post Market Change Percent | -0.03575938 |
| Post Market Price | 27.95 |
| Post Market Time | 1,787,961,598 |
| Previous Close | 28.02 |
| Price Eps Current Year | 9.397845 |
| Price Hint | 2 |
| Price To Book | 1.8704842 |
| Price To Sales Trailing12 Months | 2.501929 |
| Profit Margins | 0.06804 |
| Quick Ratio | 0.854 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | buy |
| Recommendation Mean | 2.46429 |
| Region | US |
| Regular Market Change | -0.0600014 |
| Regular Market Change Percent | -0.214138 |
| Regular Market Day High | 28.02 |
| Regular Market Day Low | 27.77 |
| Regular Market Day Range | 27.77 - 28.02 |
| Regular Market Open | 28.0 |
| Regular Market Previous Close | 28.02 |
| Regular Market Price | 27.96 |
| Regular Market Time | 1,787,947,274 |
| Regular Market Volume | 27,164,507 |
| Return On Assets | 0.05784 |
| Return On Equity | 0.05014 |
| Revenue Growth | 0.026 |
| Revenue Per Share | 11.193 |
| Sand P52 Week Change | 0.20204377 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 1 |
| Shares Outstanding | 5,699,673,589 |
| Shares Percent Shares Out | 0.026199998 |
| Shares Short | 149,271,132 |
| Shares Short Previous Month Date | 1,784,073,600 |
| Shares Short Prior Month | 163,820,439 |
| Short Name | Pfizer, Inc. |
| Short Percent Of Float | 0.026199998 |
| Short Ratio | 3.69 |
| Source Interval | 15 |
| State | NY |
| Symbol | PFE |
| Target High Price | 35.75 |
| Target Low Price | 25.0 |
| Target Mean Price | 28.60577 |
| Target Median Price | 28.0 |
| Total Cash | 11,704,000,512 |
| Total Cash Per Share | 2.053 |
| Total Debt | 63,480,000,512 |
| Total Revenue | 63,695,998,976 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 1.72 |
| Trailing Annual Dividend Yield | 0.061384726 |
| Trailing Eps | 0.76 |
| Trailing P E | 36.789474 |
| Trailing Peg Ratio | 2.7138 |
| Triggerable | 1 |
| Two Hundred Day Average | 26.08485 |
| Two Hundred Day Average Change | 1.8751488 |
| Two Hundred Day Average Change Percent | 0.07188651 |
| Type Disp | Equity |
| Volume | 27,164,507 |
| Website | https://www.pfizer.com |
| Zip | 10,001-2192 |